N/A N=40 Animal Assisted Therapy in Dentistry
Anxiety
Primary: Mean Salivary Amylase Levels Throughout Dental Visit — 150.82; 166.70; 127.77; 145.39 U/mL — p=0.379
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=168 Long Term Comparison of Two Different Techniques of Uterine Cesarean Incision Closure
Cesarean Section; Complications · Placenta Previa · Placenta Accreta
Primary: Placenta Previa — 18; 17; 0; 3 Participants
Phase 2 N=84 Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex
Tuberous Sclerosis Complex
Primary: Cognitive Assessment Scores and Developmental Impact — 83.9; 80.9; 97.3; 85.0 score on a scale — p=0.8681
N/A N=193 OxCKD1 -Empowering Healthy Lifestyle Choices in Chronic Kidney Disease
Chronic Kidney Disease
Primary: 24-hour Urinary Sodium Excretion — 93; 119 mmol/day
N/A N=90 Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer
Synchronous Metastasized Breast Cancer · Circulating Tumor Cells
Primary: Overall Survival (OS) — 34.6; 56.2 months — p=0.042
N/A N=65 The Influence of a Medication Adherence Smartphone Application on Medication Adherence in Chronic Illness
Medication Adherence · Self Efficacy
Primary: Change in Medication Adherence as Measured by the Adherence to Refills and Medications Scale (ARMS) — -4.0; -1.0 score on a scale
N/A N=159 Cardiorespiratory Fitness, Apolipoprotein E Genotype, and Cognitive Functions: A Prospective Study
Aging · Cognitive Change
Primary: Changes in Inhibitory Performance: Stroop Task — 1.66; -29.85; 21.49; -20.13 ms
N/A N=19 RTLS for Healthcare Process Validation
Workflow · Nursing
Primary: In-Room Activity Time Difference Between RTLS System and Manual Observation — 34.61; 6.63 minutes
Phase 1 N=17 Copper Balance in Healthy Participants Administered ALXN1840
Healthy
Primary: Change From Baseline in Mean Daily Copper Balance Over 2 Weeks of Repeated Daily ALXN1840 Dosing (Over Days 4 to 15) — -0.0749; 0.6901; 0.4201 mg/day
N/A N=4,497 Optimizing Care for Patients With Dementia
Alzheimer Disease
Primary: Dispensing of Psychotropic Medications — 161; 315 Participants — p=0.492
Phase 3 N=120 Metvix Photodynamic Therapy (PDT) Versus Cryotherapy in Participants With Primary Superficial Basal Cell Carcinoma
Superficial Basal Cell Carcinoma
Primary: Percentage of Participants With Histologically Confirmed Patient Complete Response (CR) 3 Months After Last Metvix PDT or Cryotherapy Cycle — 92; 90 percentage of…
N/A N=109 Peer Social Support During In Vivo Exposure for PTSD
Stress Disorders, Post-Traumatic · Anxiety Disorders · Mental Disorder
Primary: Clinical Administrated PTSD Scale (CAPS) — 25.44; 24.44 score on a scale
Early Phase 1 N=33 N-Acetyl-Cysteine (NAC) for Healing of Amputation Stumps in the Setting of Diabetes
Diabetes Mellitus · Critical Limb Ischemia · Lower Limb Amputation Knee
Primary: Change in Postoperative Laser-Assisted Fluorescent Angiography (LAFA) Perfusion. — 0.060; 0.096; 0.045; 0.031 percentage of defect
N/A N=326 Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation
Other Cancer
Primary: Functional Assessment of Cancer Therapy - Bone Marrow Transplantation (FACT-BMT) at Day 180 — 110.68; 106.89 score on a scale
N/A N=34 Comparison of Pre-op and Post-op Pectoralis Nerve Block
Breast Cancer · Postoperative Pain · Anesthesia
Primary: Pain Score Assessment Using a Visual Analog Scale-Immediately Post-surgery — 1.6; 2.3 units on a scale